Effects of diphenylhydantoin, pH and total carbon dioxide in the cerebrospinal fluid during sodium bicarbonate and ammonium chloride intake in forty mentally sub-normal epileptics.
D000136:Acid-Base Equilibrium; D000293:Adolescent; D000328:Adult; D000643:Ammonium Chloride / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D002118:Calcium / Q000134:cerebrospinal fluid; D002245:Carbon Dioxide / Q000134:cerebrospinal fluid*; D002712:Chlorides / Q000134:cerebrospinal fluid; D004827:Epilepsy / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008607:Intellectual Disability / Q000378:metabolism*; D008297:Male; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use*; D011188:Potassium / Q000134:cerebrospinal fluid; D012964:Sodium / Q000134:cerebrospinal fluid; D013053:Spectrophotometry
D001639:Bicarbonates; D002712:Chlorides; D000643:Ammonium Chloride; D002245:Carbon Dioxide; D010672:Phenytoin; D012964:Sodium; D011188:Potassium; D002118:Calcium